The Asian Journal of Advances in Orphan Pharmacotherapy (AJAOP) is a peer-reviewed, open-access scientific journal that serves as a vital platform for disseminating cutting-edge research and insights in the field of orphan drugs, rare disease therapeutics, and niche pharmacological innovations across Asia and globally.
AJAOP is published by JAG Unified International, an academic publisher dedicated to enhancing scholarly communication in emerging and underserved areas of healthcare and pharmaceutical sciences. The journal brings together a global network of researchers, clinicians, policy makers, and healthcare professionals who are working to advance treatments for rare and neglected diseases through innovation, equity, and collaborative knowledge exchange.
Our Mission
To bridge the knowledge gap in orphan pharmacotherapy by:
- Promoting high-quality scientific research
- Supporting evidence-based practices and innovation
- Encouraging interdisciplinary collaboration
- Amplifying the voices of researchers and practitioners in Asia and beyond
Our Scope
AJAOP welcomes contributions in, but not limited to:
- Development and evaluation of orphan drugs
- Clinical trials and case reports on rare diseases
- Pharmacoeconomics and policy issues in access to orphan therapies
- Regulatory frameworks and approval processes in Asia
- Personalized and genomic medicine for rare conditions
- Ethical and social considerations in rare disease management
Who We Serve
- Pharmacologists and clinical researchers
- Healthcare professionals specializing in rare diseases
- Pharmaceutical and biotech innovators
- Public health professionals and regulatory authorities
- Medical educators and students
Indexing & Visibility
The journal aims to be indexed in major academic databases and directories to ensure maximum visibility and impact for the research it publishes.
We are committed to supporting the rare disease research community with an inclusive, accessible, and ethical publishing environment. Together, let’s shape the future of orphan pharmacotherapy and improve lives through innovation.
